NasdaqGS - Delayed Quote USD
Natera, Inc. (NTRA)
165.34
+0.99
+(0.60%)
At close: June 13 at 4:00:00 PM EDT
165.46
+0.12
+(0.07%)
Pre-Market: 4:16:38 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 578,250 | 56 |
| Sales | 555,355 | 62 |
| Net Shares Purchased (Sold) | 22,895 | 118 |
| Total Insider Shares Held | 4.43M | -- |
| % Net Shares Purchased (Sold) | 0.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MARCUS GAIL BOXER Director | Sale at price 164.33 - 165.04 per share. | Direct | 657,761 | Jun 10, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 156.07 - 158.33 per share. | Direct | 960,062 | Jun 2, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 156.30 - 159.12 per share. | Direct | 471,212 | Jun 2, 2025 |
| SHEENA JONATHAN Director | Sale at price 153.95 - 164.03 per share. | Indirect | 966,633 | May 12, 2025 |
| MARCUS GAIL BOXER Director | Conversion of Exercise of derivative security at price 24.42 per share. | Direct | 97,680 | May 1, 2025 |
| MARCUS GAIL BOXER Director | Sale at price 146.34 - 153.06 per share. | Direct | 606,433 | May 1, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 148.25 - 152.04 per share. | Direct | 1,047,702 | May 1, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 148.25 - 152.04 per share. | Direct | 450,353 | May 1, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 152.18 - 155.44 per share. | Direct | 776,588 | Apr 29, 2025 |
| RABINOWITZ MATTHEW Officer and Director | Sale at price 152.18 per share. | Direct | 261,449 | Apr 28, 2025 |
| SHEENA JONATHAN Director | Sale at price 152.18 per share. | Direct | 66,808 | Apr 28, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 152.18 per share. | Direct | 943,987 | Apr 28, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 152.18 per share. | Direct | 303,300 | Apr 28, 2025 |
| FESKO JOHN President | Sale at price 152.18 per share. | Direct | 260,080 | Apr 28, 2025 |
| MOSHKEVICH SOLOMON President | Sale at price 152.18 per share. | Direct | 335,714 | Apr 28, 2025 |
| MOSHKEVICH SOLOMON President | Stock Gift at price 0.00 per share. | Direct | 0 | Apr 28, 2025 |
| ROSENMAN HERMAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 25, 2025 |
| HEALY JAMES I Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 25, 2025 |
| BOTHA ROELOF FREDERICK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 25, 2025 |
| BAYNES ROY D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 25, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 144.30 - 152.46 per share. | Direct | 321,809 | Apr 24, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | -- | Direct | -- | Apr 22, 2025 |
| SHEENA JONATHAN Director | Sale at price 145.54 - 146.16 per share. | Direct | 12,517 | Apr 21, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 145.54 - 146.16 per share. | Direct | 88,784 | Apr 21, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 145.54 - 146.07 per share. | Direct | 242,190 | Apr 21, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 145.54 - 146.16 per share. | Direct | 68,408 | Apr 21, 2025 |
| FESKO JOHN President | Sale at price 145.54 - 146.10 per share. | Direct | 49,922 | Apr 21, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 145.54 - 146.85 per share. | Direct | 43,085 | Apr 21, 2025 |
| SHEENA JONATHAN Director | -- | Direct | -- | Apr 17, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | -- | Direct | -- | Apr 17, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | -- | Direct | -- | Apr 17, 2025 |
| RABINOWITZ DANIEL A Officer | -- | Direct | -- | Apr 17, 2025 |
| SHEENA JONATHAN Director | Sale at price 132.04 - 141.28 per share. | Indirect | 826,327 | Apr 4, 2025 |
| MARCUS GAIL BOXER Director | Conversion of Exercise of derivative security at price 7.86 - 24.42 per share. | Direct | 78,967 | Apr 1, 2025 |
| MARCUS GAIL BOXER Director | Sale at price 139.33 - 142.82 per share. | Direct | 563,100 | Apr 1, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 138.41 - 142.28 per share. | Direct | 3,556,948 | Apr 1, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 139.78 - 141.90 per share. | Direct | 421,428 | Apr 1, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 138.36 - 138.41 per share. | Direct | 354,603 | Mar 31, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 138.39 - 138.41 per share. | Direct | 194,327 | Mar 31, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | -- | Direct | -- | Mar 28, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | -- | Direct | -- | Mar 28, 2025 |
| RABINOWITZ DANIEL A Officer | -- | Direct | -- | Mar 28, 2025 |
| BERTAGNOLLI MONICA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2025 |
| SHEENA JONATHAN Director | Sale at price 145.09 - 146.81 per share. | Indirect | 856,410 | Mar 18, 2025 |
| RABINOWITZ MATTHEW Officer and Director | Sale at price 146.03 - 149.58 per share. | Direct | 164,584 | Mar 17, 2025 |
| BROPHY MICHAEL BURKES Chief Financial Officer | Sale at price 146.03 - 149.58 per share. | Direct | 115,661 | Mar 17, 2025 |
| CHAPMAN STEVEN LEONARD Chief Executive Officer | Sale at price 146.03 per share. | Direct | 978,678 | Mar 17, 2025 |
| RABINOWITZ DANIEL A Officer | Sale at price 146.03 - 149.74 per share. | Direct | 135,521 | Mar 17, 2025 |
| FESKO JOHN President | Sale at price 146.03 - 149.58 per share. | Direct | 116,099 | Mar 17, 2025 |
| MOSHKEVICH SOLOMON Officer | Sale at price 146.03 - 149.74 per share. | Direct | 149,836 | Mar 17, 2025 |
Related Tickers
GH Guardant Health, Inc.
49.29
+0.55%
EXAS Exact Sciences Corporation
53.52
-0.91%
WGS GeneDx Holdings Corp.
64.57
-2.71%
TWST Twist Bioscience Corporation
33.52
-0.33%
PSNL Personalis, Inc.
6.01
+3.44%
GRAL GRAIL, Inc.
41.31
-1.46%
CDNA CareDx, Inc
18.59
-1.27%
ILMN Illumina, Inc.
86.93
-1.36%
VCYT Veracyte, Inc.
26.44
-0.94%
TMO Thermo Fisher Scientific Inc.
402.76
-2.93%